
At the conclusion of this session, participants will be able to:
- describe the clinical presentation of common opportunistic pathogens in transplant patients
- explain the limitations of culture-based diagnostic tests in immunocompromised transplant patients
- discuss the differential diagnosis of pulmonary infiltrates in the transplant recipient








D. R. Snydman,
Chimerix:
Consultant
,
Consulting fee
Merck:
Scientific Advisor
,
Consulting fee
Cubist:
Grant Investigator
and
Speaker's Bureau
,
Research grant
,
Research support
and
Speaker honorarium
Tetraphase:
Grant Investigator
,
Grant recipient
Summit:
Grant Investigator
and
Scientific Advisor
,
Consulting fee
and
Grant recipient
Actelion:
Grant Investigator
,
Grant recipient
Microbiotix:
Scientific Advisor
,
Consulting fee
Analysis Group:
Consultant
,
Consulting fee
Millenium:
Data Safety Monitoring Board
,
Consulting fee
M. Green, Merck: Research Contractor , Research support
Astellas: Research Contractor and Scientific Advisor , Consulting fee and Research support
L. Strasfeld, None
S. Deresinski, None